Annual Net Margin
-90.02%
+3419.48%+97.43%
December 31, 2023
Summary
- As of February 7, 2025, MCRB annual net profit margin is -90.02%, with the most recent change of +3419.48% (+97.43%) on December 31, 2023.
- During the last 3 years, MCRB annual net margin has risen by +178.31% (+66.45%).
- MCRB annual net margin is now -98.94% below its all-time high of -45.25%, reached on December 31, 2021.
Performance
MCRB Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Margin
N/A
September 30, 2024
Summary
- MCRB quarterly net profit margin is not available.
Performance
MCRB Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Net Margin Formula
Net Margin = Net Income
Revenue ✕ 100%
Revenue ✕ 100%
MCRB Net Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +97.4% | - |
| 3 y3 years | +66.5% | - |
| 5 y5 years | +74.3% | - |
MCRB Net Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -98.9% | +97.4% | ||
| 5 y | 5-year | -98.9% | +97.4% | ||
| alltime | all time | -98.9% | +97.4% |
Seres Therapeutics Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -90.02%(-97.4%) | -32.65%(-188.7%) |
| Jun 2023 | - | 36.81%(-100.5%) |
| Dec 2022 | -3509.50%(+7655.8%) | -7056.00%(+305.0%) |
| Sep 2022 | - | -1742.22%(-67.3%) |
| Jun 2022 | - | -5323.60%(+40.4%) |
| Mar 2022 | - | -3792.63%(+528.9%) |
| Dec 2021 | -45.25%(-83.1%) | -603.08%(-1220.3%) |
| Sep 2021 | - | 53.83%(-105.9%) |
| Jun 2021 | - | -918.30%(+48.1%) |
| Mar 2021 | - | -620.23%(+496.8%) |
| Dec 2020 | -268.33%(+31.7%) | -103.92%(-95.1%) |
| Sep 2020 | - | -2136.91%(+523.6%) |
| Jun 2020 | - | -342.66%(+41.1%) |
| Mar 2020 | - | -242.78%(-1.5%) |
| Dec 2019 | -203.68% | -246.37%(+5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | -233.38%(+171.8%) |
| Jun 2019 | - | -85.86%(-74.2%) |
| Mar 2019 | - | -332.37%(+66.0%) |
| Dec 2018 | -350.03%(+25.7%) | -200.27%(-17.4%) |
| Sep 2018 | - | -242.40%(-59.8%) |
| Jun 2018 | - | -602.49%(-14.3%) |
| Mar 2018 | - | -703.07%(-25.8%) |
| Dec 2017 | -278.44%(-33.8%) | -947.41%(+3044.4%) |
| Sep 2017 | - | -30.13%(-96.8%) |
| Jun 2017 | - | -929.60%(+10.0%) |
| Mar 2017 | - | -844.91%(+1.5%) |
| Dec 2016 | -420.74% | -832.54%(+479.8%) |
| Sep 2016 | - | -143.59%(-84.5%) |
| Jun 2016 | - | -929.19%(+27.8%) |
| Mar 2016 | - | -727.08% |
FAQ
- What is Seres Therapeutics annual net profit margin?
- What is the all time high annual net margin for Seres Therapeutics?
- What is Seres Therapeutics annual net margin year-on-year change?
- What is the all time high quarterly net margin for Seres Therapeutics?
What is Seres Therapeutics annual net profit margin?
The current annual net margin of MCRB is -90.02%
What is the all time high annual net margin for Seres Therapeutics?
Seres Therapeutics all-time high annual net profit margin is -45.25%
What is Seres Therapeutics annual net margin year-on-year change?
Over the past year, MCRB annual net profit margin has changed by +3419.48% (+97.43%)
What is the all time high quarterly net margin for Seres Therapeutics?
Seres Therapeutics all-time high quarterly net profit margin is 53.83%